Back to top
more

SONOVA HOLDING (SONVY)

(Delayed Data from OTC)

$54.89 USD

54.89
31,097

+0.30 (0.55%)

Updated Aug 7, 2025 03:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (147 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

athenahealth (ATHN) Beats Earnings, Misses Revenues in Q3

by Zacks Equity Research

athenahealth (ATHN) witnessed a year-over-year increase in Q3 revenues on the back of strength in its Business and Services segment.

    Zacks Equity Research

    Here's Why Investors Should Sell Patterson Companies Now

    by Zacks Equity Research

    Rapidly changing healthcare environment in the United States, unfavorable price movement, a competitive dental products distribution industry and integration risks pose significant challenges for Patterson Companies (PDCO).

      Zacks Equity Research

      Here's Why Investors Should Sell Ecolab (ECL) Right Away

      by Zacks Equity Research

      Intensifying competition, foreign exchange volatility, higher raw material costs and integration risks are primary headwinds for Ecolab (ECL) as of now.

        Zacks Equity Research

        OPKO Health (OPK) Signs New Agreement with Japan Tobacco

        by Zacks Equity Research

        OPKO Health's (OPK) new agreement with Japan Tobacco will enhance prospects of its kidney drug RAYALDEE in Japan.

          Zacks Equity Research

          Ecolab (ECL) to Divest Equipment Care Segment, Shares Fall

          by Zacks Equity Research

          In August, management at Ecolab (ECL) announced that equipment care business has been witnessing a quiet period, registering just 2% growth on a year-over-year basis in the last quarter.

            Zacks Equity Research

            Veeva Systems (VEEV) Rides High on Commercial Cloud Platform

            by Zacks Equity Research

            The cost-effectiveness of cloud-based applications over in-premise applications is attracting life science companies. Veeva's (VEEV) industry-specific focus lends it a significant leverage.

              Zacks Equity Research

              Teleflex (TFX) Hits a 52-Week High on NeoTract Acquisition

              by Zacks Equity Research

              NeoTract acquisition is expected to generate mid-single digit constant currency revenue growth for the next several years and enhance Teleflex's (TFX) margins.

                Zacks Equity Research

                PerkinElmer Hits a 52-Week High: What's Driving the Stock?

                by Zacks Equity Research

                PerkinElmer's (PKI) portfolio has not only boosted the company's organic growth trajectory but has also helped boost market share worldwide. Solid estimate revision trend boosts investor confidence.

                  Zacks Equity Research

                  AngioDynamicis' (ANGO) Solero MTA System to Drive Growth

                  by Zacks Equity Research

                  Growth in the core Angiographic Catheter business is also likely to fortify the company's footprint in the global space.

                    Zacks Equity Research

                    AngioDynamics (ANGO) Misses on Earnings & Revenues in Q1

                    by Zacks Equity Research

                    AngioDynamics' (ANGO) adjusted gross margin decreased year over year owing to voluntary market withdrawal of the Acculis Microwave Tissue Ablation System.

                      Zacks Equity Research

                      Masimo RAS-45 Full-Market Release to Boost Respiratory Care

                      by Zacks Equity Research

                      Masimo Corporation's (MASI) newly launched RAS-45, a single use adhesive respiration sensor would strengthen the company's foothold in the growing global respiratory care market.

                        Zacks Equity Research

                        Baxter Announces Launch of DeviceVue System for Sigma Pumps

                        by Zacks Equity Research

                        Baxter's (BAX) latest development is expected to fortify its foothold in the smart pumps market.